Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Proof-of-concept Study Evaluating the Safety and Efficacy of Bevacizumab in the Treatment of Adhesive Capsulitis

NCT06976671 is registered in ClinicalTrials.gov with Macquarie University, Australia as lead sponsor.

NCT NCT06976671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06976671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Proof-of-concept Study Evaluating the Safety and Efficacy of Bevacizumab in the Treatment of Adhesive Capsulitis
Lead sponsor
Macquarie University, Australia
Phase
Phase 2
Overall status
Recruiting
Start date
September 10, 2024
Completion date
September 30, 2027
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhesive capsulitis